Examination of the symptom by a pharmacist performing continuously inhalational instruction for the asthmatic patients who newly introduced Symbicort Tubuhaler.

Examination of the symptom by a pharmacist performing continuously inhalational instruction for the asthmatic patients who newly introduced Symbicort Tubuhaler. - Examination of the symptom by a pharmacist performing continuously inhalational instruction for the asthmatic patients who newly introduced Symbicort Tubuhaler.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000029730

Enrollment

Registered

2017-11-01

Start date

2017-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchial asthma

Interventions

Continuously inhalational instruction by the pharmacist. Four times of intervention (in the first time and the first month, the second month, the fourth month). Only as for the initial inhalational i

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patient with asthma bronchial using Symbicort Turbuhaler for the first time.

Exclusion criteria

Exclusion criteria: 1. The patients who remarkably have low understanding degree. 2. The patients with the sequelae that the movement of the finger is confined to remarkably. 3. In addition, the patients whom a study person in charge judged to be inadequate as subjects.

Design outcomes

Primary

Measure	Time frame
Change of Asthma Control Test (ACT) six months after initial instruction.	—

Secondary

Measure	Time frame
1.Technique of using inhalation device 2.Peak flow rate	—

Countries

Japan

Contacts

Public ContactAkihiro Goto

Juntendo university Shizuoka hospital Drug department

a-gotou@juntendo.ac.jp0559483111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026